New Afrezza prescribing information outlines higher starting dose conversions for patients transitioning from mealtime ...
The FDA has approved a label update for an inhaled insulin indicated for adults with type 1 or type 2 diabetes, according to ...
InvestorsHub on MSN
MannKind shares climb after FDA clears revised Afrezza prescribing label
MannKind Corporation (NASDAQ:MNKD) shares gained 3.5% on Monday after the company said the U.S. Food and Drug Administration ...
Updated initial conversion table based on clinical trials in adults showing significantly improved mealtime glycemic ...
Male and female patients (n = 416) with type 1 diabetes were screened at 41 centers across the U.S. and Canada. Inclusion criteria were as follows: 1) diabetes duration for 1 year or more; 2) age ...
If you’re on insulin to treat type 1 or type 2 diabetes, it’s critical to know exactly how to use it. “Insulin can be a very dangerous drug if used improperly,” says Stanley Mathew, MD, an ...
The Azores Health Service will reimburse 100% of the cost of medical devices for the treatment of type 1 diabetes mellitus ...
Of the 416 subjects screened, 335 were randomly assigned to receive treatment and one subject withdrew; therefore, 334 subjects received treatment (of whom 312 were evaluable for efficacy) and 303 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results